IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Industrial Biotech

BASF Commercializes Bacteria that Cleans Teeth

9:40 AM MDT | April 2, 2009 | Alex Scott

BASF says it has begun taking steps to commercialize a strain of Lactobacillus, a pro-biotic micro-organism, which it has engineered to protect against bacteria that cause cavities in teeth.   BASF says it has been collaborating with biotech firm OrganoBalance (Berlin) to commercialize the technology named pro-t-action. Financial terms between the two companies have not been disclosed. The strain of Lactobacillus developed by BASF and OrganoBalance binds to cavity-forming Streptococcus mutans bacteria found in the mouth, clumping them together so that they...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa